Cargando...
Fasting reduces the incidence of vincristine‐associated adverse events in dogs
Fasting has been shown to decrease chemotherapy‐associated adverse events (AEs), in part through insulin‐like growth factor (IGF‐1) reduction, and may induce a protective effect on normal cells during chemotherapy treatment in mice and people. The purpose of this study was to evaluate the effect of...
Gardado en:
| Publicado en: | Vet Comp Oncol |
|---|---|
| Main Authors: | , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
Blackwell Publishing Ltd
2020
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7891372/ https://ncbi.nlm.nih.gov/pubmed/33448618 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/vco.12638 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|